NEW ZEALAND GAZETTE

No. 78

2066

Salicylic acid; in medicines containing more than 40%

Silver sulfadiazine; except for external use in packs containing 50 grams or less

Sodium picosulfate; in preparations for bowel cleansing prior to diagnostic, medical or surgical procedures

Schedule 3

Pharmacy-only Medicines

Aciclovir; for external use for the treatment of herpes labialis except in medicines containing 5% or less and in tubes containing 3 grams or less

Amethocaine; for external use in medicines containing 10% or less and more than 2%

Atropa belladonna; for external use in medicines containing 0.03% of the alkaloids of belladonna; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna

Atropine; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose; in medicines containing atropine sulfate for the treatment or organophosphorous poisoning either in packs of up to 20 tablets containing 0.6 milligrams or less per tablet or in injections in packs of 5 or less containing 0.6 milligrams per millilitre or less; except when used as an antidote in a device designed for self-injection; except when sold by licensees under the Toxic Substances Regulations

Benzocaine; for external use in medicines containing 10% or less and more than 2%

Benzydamine; for external use

Bifonazole; for external use except in medicines for tinea pedis only or in shampoos containing 1% or less

Cinchocaine; for external use in medicines containing 0.5% or less

Datura spp; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

Diclofenac; in solid dose form containing 12.5 milligrams or less per dose form in packs of not more than 20 tablets or capsules

Duboisia leichhardtii; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

Duboisia myoporides; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

Flurbiprofen; in throat lozenges containing 10 milligrams or less per lozenge

Folic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose

Folinic acid; for oral use in medicines containing more than 500 micrograms per recommended daily dose

Glyceryl trinitrate; for external use; except in medicines containing 100 micrograms or less per litre or per kilogram

Hyoscine; for transdermal use in medicines containing 2 milligrams or less of total solanaceous alkaloids per dose unit; for oral use in liquid form in medicines containing 0.03% and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose unit and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

Hyoscyamine; for external use in medicines containing 0.03% or less of total solanaceous alkaloids; for oral use in liquid form in medicines containing 0.03% and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose unit and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

Hyoscyamus niger; for oral use in liquid form in medicines containing 0.03% and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose unit and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids

*Ibuprofen; for external use; for oral use in either liquid form in packs containing not more than 4 grams or in solid dose form containing not more than 200 milligrams per dose form and when in medicines which have received the consent of the Minister or the Director-General to their sale as pharmacy-only medicines and which are sold in the manufacturer's original pack

Injectable medicines; except when specified elsewhere in the Schedule; except for Factor VIII; except for contrast media, parenteral nutrition replacement preparations, plasma volume expanders or intraocular viscoelastic preparations

Lignocaine; for external use in medicines containing 10% or less and more than 2%; for urethral use

Minoxidil; for external use in medicines containing 5% or less

Nicotine; for inhalation except when sold from a smoking cessation clinic run under the auspices of a registered medical practitioner, nurse, pharmacist or psychologist

Nystatin; for dermal use

Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin

Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin

Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 0.5% or less

Potassium chlorate; except in medicines containing 10% or less

Prilocaine; for dermal use in medicines containing 10% or less

Pyrithione zinc; for external use in medicines containing more than 2%